$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled release preparation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/48
출원번호 US-0213518 (1994-03-16)
우선권정보 SE-0001057 (1993-03-30)
발명자 / 주소
  • Olsson Birgitta (Stenhamra SEX) Pesonen Maritta A. (Skarholmen SEX) Ragnarsson Gert (Bro SEX)
출원인 / 주소
  • Pharmacia & Upjohn Aktiebolag (Stockholm SEX 03)
인용정보 피인용 횟수 : 80  인용 특허 : 0

초록

An oral controlled release pharmaceutical preparation in the form of a tablet, capsule or sachet containing a plurality of coated particles comprising a therapeutically effective amount of a salt of morphine coated with a barrier membrane providing a controlled, preferably pH-independent, release of

대표청구항

An oral controlled release pharmaceutical preparation in the form of a multiple unit hard gelatin capsule enclosing particles containing a therapeutically effective amount of a salt of morphine for administration once daily characterized in that it consists of at least 50 particles with a size in th

이 특허를 인용한 특허 (80)

  1. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  2. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  3. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  4. Habib, Walid; Hamed, Ehab; Moe, Derek; Kraling, Carrie; Hillman, Lisa, Abuse resistant drug formulation.
  5. Tygesen, Peter Holm; Lindhardt, Karsten; Olsen, Martin Rex; Fischer, Gina Engslev; Overgard, Jan Martin; Boye, Georg; Skak, Nikolaj; Elhauge, Torben, Abuse-deterrent pharmaceutical compositions for controlled release.
  6. Hamed, Ehab, Alcohol-resistant metoprolol-containing extended-release oral dosage forms.
  7. Glidden, Paul F.; Pilgrim, Alison J.; Hanson, Stephen R., Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor.
  8. Glidden, Paul F.; Pilgrim, Alison J.; Hanson, Stephen R., Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor.
  9. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  10. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  11. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  12. Oshlack, Benjamin; Huang, Hua Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  13. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  14. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  15. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  16. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  17. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  18. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  19. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  20. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  21. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  22. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  23. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  24. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  25. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  26. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  27. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  28. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  29. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  30. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  31. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  32. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  33. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  34. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  35. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  36. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  37. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  38. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  39. Oshlack, Benjamin; Masselink, John K.; Huang, Hua-Pin; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  40. Hemmingsen, Pernille Hoyrup; Pedersen, Anders Vagno; Bar-Shalom, Daniel, Controlled release pharmaceutical compositions for prolonged effect.
  41. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F., Extruded extended release abuse deterrent pill.
  42. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F., Extruded extended release abuse deterrent pill.
  43. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F., Extruded immediate release abuse deterrent pill.
  44. Szymczak, Christopher E., Film forming compositions containing sucralose.
  45. Andersen, Christine; Lindhardt, Karsten; Oevergaard, Jan Martin; Lyhne-Iversen, Louise Inoka; Olsen, Martin Rex; Haahr, Anne-Mette; Hoeyrup Hemmingsen, Pernille Kristine, Formulations and methods for the controlled release of active drug substances.
  46. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F.; Hart, Matthew N., Immediate release abuse deterrent liquid fill dosage form.
  47. Tygesen, Peter Holm; Oevergaard, Jan Martin; Oestman, Joakim, Immediate release composition resistant to abuse by intake of alcohol.
  48. Tygesen, Peter Holm; Oevergaard, Jan Martin; Oestman, Joakim, Immediate release composition resistant to abuse by intake of alcohol.
  49. Gulian, Cynthia; Gowan, Jr., Walter G.; Parekh, Kishor B.; Morris, Joseph M.; Markley, Thomas J.; Wieand, Dennis C.; McNally, Gerard P.; Szymczak, Christopher, Method for dip coating dosage forms.
  50. Sackler Richard ; Kaiko Robert ; Goldenheim Paul, Method of treating humans with opioid formulations having extended controlled release.
  51. Sackler, Richard; Kaiko, Robert; Goldenheim, Paul, Method of treating humans with opioid formulations having extended controlled release.
  52. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  53. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  54. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  55. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  56. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  57. Fischer, Gina; Bar-Shalom, Daneil; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
  58. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
  59. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
  60. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine polymer release system.
  61. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-A day oxycodone formulations.
  62. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-a-day oxycodone formulations.
  63. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-a-day oxycodone formulations.
  64. Wimmer, Walter; Brogmann, Bianca; Hahn, Udo; Spitzley, Christof, Opioid analgesic.
  65. Chasin Mark ; Oshlack Benjamin ; Pedi ; Jr. Frank, Opioid formulations having extended controlled release.
  66. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Opioid polymer release system.
  67. Oshlack Benjamin ; Chasin Mark, Orally administrable opioid formulations having extended duration of effect.
  68. Oshlack Benjamin ; Chasin Mark, Orally administrable opioid formulations having extended duration of effect.
  69. Oshlack, Benjamin; Chasin, Mark, Orally administrable opioid formulations having extended duration of effect.
  70. Oshlack,Benjamin; Chasin,Mark, Orally administrable opioid formulations having extended duration of effect.
  71. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Oxycodone formulations.
  72. Miller, Ronald Brown; Leslie, Stewart Thomas; Malkowska, Sandra Therese Antoinette; Prater, Derek Allan; Knott, Trevor John; Mohammad, Hassan, Pharmaceutical formulation.
  73. Ronald Brown Miller CH; Stewart Thomas Leslie GB; Sandra Therese Antoinette Malkowska GB; Derek Allan Prater GB; Trevor John Knott GB; Hassan Mohammad GB, Pharmaceutical formulation.
  74. Miller Ronald Brown,CHX ; Leslie Stewart Thomas,GB2 ; Malkowska Sandra Therese Antoinette,GB2 ; Knott Treavor John,GB2 ; Challis Deborah,GB2 ; Prater Derek Allan,GB2 ; Heafield Joanne,GB2, Pharmaceutical multiparticulates.
  75. Kamath,Satish, Polyacrylic film forming compositions.
  76. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Lademann, Anne-Marie; Andersen, Christine, Polymer release system.
  77. Boehm, Garth, Sequestering subunit and related compositions and methods.
  78. Heafield Joanne,GBX ; Knott Trevor John,GBX ; Leslie Stewart Thomas,GBX ; Malkowska Sandra Therese Antoinette,GBX ; Miller Ronald Brown,CHX ; Prater Derek Allan,GBX ; Smith Kevin John,GBX, Sustained release compositions and a method of preparing pharmaceutical compositions.
  79. Heafield Joanne,GB2 ; Knott Trevor John,GB2 ; Leslie Stewart Thomas,GB2 ; Malkowska Sandra Therese Antoinette,GB2 ; Miller Ronald Brown,CHX ; Prater Derek Allan,GB2 ; Smith Kevin John,GB2, Sustained release compositions of morphine and a method of preparing pharmaceutical compositions.
  80. Busetti Cesare,ITX ITX 20149 ; Crimella Tiziano,ITX ITX 20154, Time-specific controlled release capsule formulations and method of preparing same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로